Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
4,838.00    104.00 (2.20%)
Bid:
4,852.00
Ask:
4,862.00
Spread: 10.00 (0.206%)
Market Cap: £3.52b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Interim Management Statement

13 Oct 2011 11:05

RNS Number : 1203Q
Renishaw PLC
13 October 2011
 



 

Renishaw plc

Interim management statement

 

This statement has been prepared for the Group and relates to the three months ended 30th September 2011. It contains unaudited information that covers the first quarter and the period since.

 

Trading activity

Revenue for the three months to 30th September 2011 was £70.5m, an increase of 15.0% over the £61.3m for the first quarter of the previous year but below planned-for revenue. The previous year has been restated for the inclusion of Measurement Devices Limited from July 2010, which was initially accounted for as an associate company.

 

Geographically, Europe reported growth of 26% over the comparable period last year and the Americas a growth of 21%. The Far East, an area of significant growth last year, showed revenue for this quarter at a similar level to the corresponding quarter last year. By market sector, we have seen a slowdown in one of our product lines sold to the electronics industries.

 

Profit before tax for the first quarter amounted to £13.6m, compared with £15.1m last year.

 

The Group has increased its cost base compared with the comparable period last year, mainly by the addition of personnel to support its growing revenue and production demands, and investment in its research and development programmes. Headcount at the end of September 2011 was 2,745, an increase of 70 from the start of the financial year at 1st July 2011 and an increase of 538 over the 2,207 personnel at 30th September 2010.

 

Significant events and financial position

We are reviewing our healthcare business and have refocused part of the activities to a smaller number of projects, with some resources diverted to our metrology business.

 

The purchase of the Miskin premises, close to Cardiff in South Wales, was completed on 30th September 2011 and the Group also acquired premises for its Canadian and Italian subsidiaries. The aggregate cost of these acquisitions was £9.0m.

 

The Group continues to have a strong balance sheet with net cash balances at 30th September 2011 of £29.3m (30th June 2011 £34.6m).

 

I should like to thank our staff for their continuing efforts and support.

 

Outlook

It is still very early in the financial year and the Group traditionally has an order book of a little over one month's sales value. During the first quarter order intake has exceeded revenue and the Group has an order book of £31.9m at the end of September 2011.

 

Due to current uncertainties surrounding the global economy, the Board is closely monitoring the Group's costs and future recruitment strategy. Despite near-term challenges caused by the economic environment, we remain focused on positioning the Group for further long-term growth.

 

 

 

 

 

Sir David McMurtry CBE, RDI, FRS, FREng, CEng, FIMechE

Chairman and Chief Executive

 

13th October 2011

 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

Telephone number 01453 524524

Website www.renishaw.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMJBMTMBMBBIB
Date   Source Headline
16th Oct 201410:04 amRNSInterim Management Statement
3rd Oct 20147:00 amRNSTrading Statement
10th Sep 201410:04 amRNSDirector/PDMR Shareholding
4th Sep 201411:56 amRNSDirectorate Change
22nd Aug 20148:22 amRNSAnnual Financial Report
12th Aug 20142:11 pmRNSDirector/PDMR Shareholding
23rd Jul 20147:00 amRNSFinal Results
8th Jul 20147:28 amRNSNotice of Results
12th Jun 20147:27 amRNSHolding(s) in Company
20th May 20147:39 amRNSDirector/PDMR Shareholding
14th May 20147:00 amRNSInterim Management Statement
11th Mar 20147:00 amRNSStatement re Investor day
30th Jan 20147:00 amRNSHalf Yearly Report
13th Jan 20141:58 pmRNSNotice of Results
19th Dec 201310:34 amRNSHolding(s) in Company
27th Nov 20138:38 amRNSDirector/PDMR Shareholding
18th Nov 201311:31 amRNSForm 8.3 - Delcam PLC
7th Nov 20137:06 amRNSStatement re offer for shareholding in Delcam plc
17th Oct 20131:41 pmRNSResult of AGM
17th Oct 201310:55 amRNSInterim Management Statement
8th Oct 20133:25 pmRNSStatement re date of Interim management statement
19th Sep 20134:09 pmRNSDirector/PDMR Shareholding
23rd Aug 20139:57 amRNSAnnual Financial Report
21st Aug 20131:41 pmRNSDirectorate Change
24th Jul 20137:00 amRNSFinal Results
22nd Jul 20131:07 pmRNSNotice of Results
18th Jul 20137:36 amRNSHolding(s) in Company
3rd May 20137:00 amRNSInterim Management Statement
23rd Apr 20137:40 amRNSHolding(s) in Company
22nd Apr 20131:32 pmRNSStatement re Date of Interim managment statement
11th Apr 201312:15 pmRNSDirectorate Change
31st Jan 20131:27 pmRNSHolding(s) in Company
30th Jan 20137:07 amRNSStatement re webcast of interim results
30th Jan 20137:00 amRNSHalf Yearly Report
16th Jan 201310:34 amRNSHolding(s) in Company
21st Dec 201210:45 amRNSDirector/PDMR Shareholding
17th Dec 20123:45 pmRNSDirector/PDMR Shareholding
8th Nov 20127:42 amRNSDirector/PDMR Shareholding
31st Oct 20129:49 amRNSStatement re shareholders voting agreement
22nd Oct 201210:13 amRNSDirector/PDMR Shareholding
18th Oct 20122:11 pmRNSResult of AGM
18th Oct 201210:30 amRNSInterim Management Statement
10th Oct 20127:22 amRNSDirectorate Change
20th Sep 201212:13 pmRNSDirector Declaration
13th Sep 20123:27 pmRNSDirector/PDMR Shareholding
24th Aug 20128:47 amRNSAnnual Report and Accounts 2012 and Notice of AGM
2nd Aug 20127:53 amRNSDirector/PDMR Shareholding
25th Jul 20127:00 amRNSFinal Results
23rd Jul 20121:19 pmRNSNotice of Results
15th May 20127:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.